Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
5.39
Dollar change
+0.45
Percentage change
9.11
%
IndexRUT P/E- EPS (ttm)-5.54 Insider Own5.77% Shs Outstand139.51M Perf Week1.89%
Market Cap754.33M Forward P/E29.69 EPS next Y0.18 Insider Trans0.00% Shs Float131.87M Perf Month34.75%
Income-545.06M PEG- EPS next Q-0.91 Inst Own55.75% Short Float41.58% Perf Quarter-3.06%
Sales983.71M P/S0.77 EPS this Y83.36% Inst Trans3.21% Short Ratio5.85 Perf Half Y-35.53%
Book/sh-5.14 P/B- EPS next Y120.17% ROA-26.50% Short Interest54.83M Perf Year-21.43%
Cash/sh4.14 P/C1.30 EPS next 5Y- ROE- 52W Range3.53 - 11.36 Perf YTD12.29%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-52.55% Beta1.58
Dividend TTM- Quick Ratio0.67 Sales past 5Y513.29% Gross Margin67.00% 52W Low52.59% ATR (14)0.52
Dividend Ex-Date- Current Ratio0.70 EPS Y/Y TTM34.19% Oper. Margin-56.11% RSI (14)58.60 Volatility12.27% 8.90%
Employees1543 Debt/Eq- Sales Y/Y TTM-50.36% Profit Margin-55.41% Recom2.50 Target Price15.40
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q36.83% Payout- Rel Volume1.57 Prev Close4.94
Sales Surprise-9.54% EPS Surprise-221.43% Sales Q/Q-18.48% EarningsFeb 28 BMO Avg Volume9.37M Price5.39
SMA2023.91% SMA5019.46% SMA200-18.21% Trades Volume14,735,938 Change9.11%
Date Action Analyst Rating Change Price Target Change
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Feb-23-22Reiterated B. Riley Securities Buy $315 → $265
Feb-22-22Resumed Jefferies Buy $198
Mar-01-24 05:25AM
Feb-29-24 04:02PM
11:13AM
11:12AM
Feb-28-24 10:49PM
12:58PM Loading…
12:58PM
10:38AM
10:16AM
10:00AM
09:52AM
09:10AM
09:00AM
08:34AM
08:17AM
08:11AM
08:11AM Loading…
08:11AM
08:00AM
08:00AM
Feb-27-24 05:30AM
Feb-26-24 02:46AM
Feb-23-24 07:35AM
Feb-22-24 03:52PM
01:39PM
12:39PM
11:09AM
09:47AM
06:21AM
06:10AM
06:00AM
06:00AM
10:00AM Loading…
Feb-20-24 10:00AM
09:25AM
Feb-15-24 04:01PM
05:17AM
Feb-11-24 05:00PM
Feb-05-24 09:20AM
Feb-03-24 08:07PM
05:35AM
Feb-01-24 05:04AM
Jan-31-24 01:33PM
11:17AM
08:22AM
08:15AM
08:08AM
05:06AM
Jan-29-24 08:15AM
Jan-28-24 07:25AM
03:15AM
Jan-27-24 08:45AM
Jan-25-24 11:34AM
Jan-23-24 09:13AM
Jan-15-24 04:05PM
02:21PM
Jan-10-24 07:35AM
Jan-09-24 05:21AM
Jan-03-24 09:25AM
Jan-02-24 05:06AM
Dec-28-23 06:45AM
Dec-25-23 05:23AM
Dec-20-23 11:02AM
Dec-18-23 08:00AM
12:55AM
Dec-14-23 02:10PM
Dec-13-23 08:00AM
Dec-05-23 04:40PM
04:07PM
04:01PM
Dec-01-23 04:00PM
Nov-30-23 12:16PM
07:00AM
Nov-29-23 11:53AM
Nov-28-23 06:28AM
06:07AM
06:00AM
Nov-22-23 10:44AM
Nov-17-23 07:15AM
Nov-15-23 05:20AM
Nov-11-23 05:30AM
Nov-10-23 01:28PM
09:25AM
09:06AM
Nov-09-23 11:28AM
10:57AM
09:40AM
08:22AM
08:06AM
08:00AM
07:52AM
01:00AM
Nov-02-23 10:00AM
09:25AM
Nov-01-23 03:10PM
10:43AM
Oct-31-23 04:37PM
12:58PM
Oct-18-23 08:05AM
08:00AM
Oct-17-23 10:17AM
06:00AM
Oct-16-23 04:07PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DDec 14Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16Option Exercise8.044,15533,40647,065Jun 21 04:40 PM
Glenn Gregory MPresident, R&DMar 10Option Exercise6.526,29841,06320,771Mar 14 05:16 PM
Trizzino JohnEVP, CCO and CBOMar 10Option Exercise6.524,60930,05111,531Mar 14 05:20 PM
Kelly James PatrickEVP, CFO and TreasurerMar 10Option Exercise6.524,60930,0515,832Mar 14 05:19 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 10Option Exercise6.524,60930,05113,058Mar 14 05:18 PM
Glenn Gregory MPresident, R&DMar 10Buy6.501,0006,50014,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 07Buy7.042,00014,08813,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 06Buy7.483,00022,45411,473Mar 14 05:16 PM